HHS Challenges AstraZeneca’s Motion for Summary Judgement in IRA Lawsuit

The Department of Health and Human Services on Wednesday filed its opposition to AstraZeneca’s motion for summary judgement in a legal case regarding the Inflation Reduction Act’s Drug Price Negotiation Program.

AstraZeneca filed its lawsuit against HHS in August 2023 calling into question a guidance document from the Centers for Medicare and Medicaid Services (CMS), which outlines the selection criteria for medicines that would be affected by the first round of drug price negotiations. The company filed a motion for summary judgement in September 2023.